Rejection chronic renal
Clinical trials for Rejection chronic renal explained in plain language.
Never miss a new study
Get alerted when new Rejection chronic renal trials appear
Sign up with your email to follow new studies for Rejection chronic renal, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a cancer drug protect new kidneys from scarring?
Disease control By invitation onlyThis phase 2 trial tests whether adding belumosudil (Rezurock) to standard care can prevent scarring in new kidney transplants. About 40 adults receiving their first or second kidney will be randomly assigned to get the drug or a placebo for a year. The study tracks serious side …
Matched conditions: REJECTION CHRONIC RENAL
Phase 2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Blood test may spot kidney transplant rejection without a biopsy
Diagnosis OngoingThis study tests whether a blood test measuring donor-derived cell-free DNA can reliably detect kidney transplant rejection. Researchers will compare the test results with kidney biopsy findings in 5,000 transplant recipients across multiple countries. The goal is to see if this …
Matched conditions: REJECTION CHRONIC RENAL
Sponsor: Paris Translational Research Center for Organ Transplantation • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC